Physician profile
Sonny Joy
NPI 1508440314
$637.14
in general payments reported to CMS, 2019-2025
15 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.92 · 2022: $19.22 · 2023: $15.60 · 2024: $82.33 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $125.00 | 2025 | Qelbree |
| Abbvie INC. | $122.83 | 2025 | |
| Glaxosmithkline, LLC. | $85.03 | 2021-2024 | Bexsero |
| Exact Sciences Corporation | $83.90 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $36.42 | 2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Kowa Pharmaceuticals America, INC. | $31.59 | 2024-2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $22.14 | 2024 | Fasenra |
| Phadia US INC. | $19.28 | 2025 | Immunocap |
| Collegium Pharmaceutical, INC. | $17.49 | 2025 | Jornay Pm |
| Corium, LLC | $17.21 | 2024 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $17.00 | 2025 | Neffy |
| Seqirus USA INC | $16.98 | 2025 | Flucelvax |
| Regeneron Healthcare Solutions, INC. | $15.60 | 2023 | Dupixent |
| Cranial Technologies, INC | $14.00 | 2024 | Doc Band |
| Cumberland Pharmaceuticals, INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonny Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.